Objectionable Microorganisms in Biopharmaceutical Manufacturing

Recorded Webinar | Carl Patterson | From: Mar 10, 2020 - To: Dec 31, 2020

Training Options & Pricing

Error Conference Exists In Wish-list.

Congrats Conference Added In Wish-list.

Recording     $229
DVD     $249
Recording + DVD     $379
Transcript (Pdf)     $229
Recording & Transcript (Pdf)     $369
DVD & Transcript (Pdf)     $379


Description

This webinar will discuss the regulations pertaining to objectionable microorganisms, agency expectations, methods to identify objectionable microorganisms, interpreting results, and controls to put into place.

Areas Covered:-

  • Definition of objectionable microorganisms
  • Regulations pertaining to objectionable microorganisms
  • Identifying objectionable microorganisms
  • Tests to determine objectionable microorganisms
  • Sources of objectionable microorganisms
  • Actions to reduce objectionable microorganism

Why Should You Attend?

Objectionable microorganisms are considered if discovered, harmful to the patient. By identifying and controlling these microorganisms and putting the appropriate controls into place early in the pharmaceutical or medical device manufacturing process, problems in the patient can be prevented.

This webinar will review the regulations pertaining to objectionable microorganisms, testing and identifying objectionable microorganisms, and putting appropriate controls into place to prevent harm to the patient. By knowing, where, when, why, and how objectionable microorganisms exist, harmful consequences to the patient can be prevented.

Who Will Benefit?

  • Quality Assurance Managers and Directors
  • Quality Control Personnel
  • Production Managers
  • Microbiology Analysts and Technicians
  • Consultants
  • Regulatory and Compliance Management
  • Regulatory Affairs Professionals